Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000–2002)
Introduction
Invasive aspergillosis (IA) has emerged as a major infectious complication in immunocompromised patients.1, 2 Indeed, the number of patients with risk factors for IA is increasing with the development of new intensive chemotherapy regimens for solid or haematological malignancies and with the growing number of stem cell and solid organ transplantations. This infection is noteworthy because of its poor prognosis and the possibility of acquisition by inhalation of conidia present in the hospital environment.1 Critical periods of immunosuppression (agranulocytosis after chemotherapy or following transplantation) often coincide with the patient's hospital stay and, consequently, hospital acquisition is possible. Thus, outbreaks of nosocomial infection are recognized and have been attributed to factors such as ongoing construction and fire-proofing material.3, 4, 5 The Centers for Disease Control and Prevention (CDC) have established the need for epidemiological surveillance of pulmonary IA in hospitals.6 In France, two official guidelines concerning IA prevention recently recommended epidemiological surveillance of IA in hospitals. It is mandatory to report nosocomial IA cases to health authorities.7, 8 IA surveillance started in Grenoble University Hospital in January 2000. This article reports the results of a three-year surveillance.
Section snippets
Hospital settings
Grenoble University Hospital was built in 1972 and has 2005 beds, with specialized units such as haematology, intensive care, infectious diseases, respiratory, etc. Solid organ transplantations (lung, kidney, liver, heart) are performed in certain surgical and intensive care units. The hospital comprises one central building with an 85% opacimetric air filtration efficiency, and peripheral wings without any air filtration. All high-risk units (haematology, oncology, intensive care, infectious
Results
This epidemiological study was performed between January 2000 and December 2002. During this period, 490 clinical/radiological or mycological alerts were reported. Among these, 74 cases of IA were suspected after evaluation of risk factors: six (8%) cases were proven, 36 (49%) cases were probable, and 32 (43%) cases were possible.
Discussion
Epidemiological surveillance of IA is recommended by the CDC and the French Consensus Conference on IA Prevention, and is a French legal requirement.6, 7, 8 However, there is no standardization of epidemiological surveillance. Published data are difficult to analyse and compare for the following reasons. Firstly, there is heterogeneity of IA definitions in the literature. Before 2000, there were no consensual criteria for IA. In 2000, the EORTC established international criteria for the
Acknowledgements
We wish to thank all the physicians of Grenoble University Hospital and Dr A. Thabuis who contributed to the IA surveillance.
References (33)
- et al.
Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients
J Hosp Infect
(2001) - et al.
Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area
J Hosp Infect
(2002) - et al.
Aspergillus airway colonization and invasive disease after lung transplantation
Chest
(1997) Invasive aspergillosis
Clin Infect Dis
(1998)Aspergillus fumigatus and aspergillosis
Clin Microbiol Rev
(1999)- et al.
Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms
J Infect Dis
(1991) Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis
Infect Control Hosp Epidemiol
(1994)- et al.
Control of construction associated nosocomial aspergillosis in an antiquated hematology unit
Infect Control Hosp Epidemiol
(1996) Guidelines for prevention of nosocomial pneumonia
Morb Mortal Wkly Rep CDC Surveill Summ
(1997)Conférence de consensus: prévention du risque aspergillaire chez les patients immunodéprimés
HygièneS
(2000)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus
Clin Infect Dis
Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the platelia test for diagnosing invasive aspergillosis
J Clin Microbiol
Elaboration and setting up of a multicentre protocol for control of filamentous fungal environment in haematological wards
J Mycol Med
Surveillance épidémiologique de l'aspergillose invasive: dans quels services, quels dénominateurs, place de la surveillance multicentrique
HygièneS
Le réseau de surveillance épidémiologique de l'aspergillose invasive nosocomiale de l'Assistance Publique des Hôpitaux de Paris
Ann Intern Med (Paris)
Cited by (28)
Spatial and temporal analyses to investigate infectious disease transmission within healthcare settings
2014, Journal of Hospital InfectionCitation Excerpt :Only four studies described the spatial distribution of cases to show the impact of hospital renovations34 or the layout of cases across specialities,16,27,34,35 with the majority of studies describing temporal trends in cases.36,37 Most case reporting studies examined bacteria (62%); however, the most informative studies were those examining organisms such as Aspergillus spp. and Legionella spp., where environmental contamination is considered to be the primary risk factor.15,35,38–42 Investigations that described the temporal or spatial distribution of cases were categorized as basic epidemiology (18%, N = 26) (Table II).
Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital
2012, Journal of InfectionCitation Excerpt :As previously defined, cases of IA were considered nosocomial if the first symptoms appeared 10 days or more after the patient's admission, and community-acquired if signs of IA were already present at admission with no hospitalization in the 10 previous days. Other cases were classified as undetermined origin.9,25 For all nosocomial IA (NIA) cases, previous hospital stays (longer than 48 h) within the 3 months before IA were recorded.
Antifungal prophylaxis in haematology patients: The role of voriconazole
2012, Clinical Microbiology and InfectionCitation Excerpt :The overall developments in epidemiology are of concern because IFIs are associated with substantial mortality. In Europe, mortality rates range from 27 to 94% for IA and from 28 to 59% for invasive candidiasis [10,16–24]. Although early initiation of therapy is vital for improving treatment outcomes, the timely diagnosis and treatment of IFIs pose considerable challenges [3,25,26].
Community-acquired invasive aspergillosis and outdoor filamentous fungal spore load: A relationship?
2011, Clinical Microbiology and InfectionMobile air-decontamination unit and filamentous fungal load in the hematology ward: How efficient at the low-activity mode?
2009, American Journal of Infection ControlInfluence of internal and outdoor factors on filamentous fungal flora in hematology wards
2009, American Journal of Infection Control